/WWHC
WWHC Stock - W World Corp.
Financial Services|Shell CompaniesOTC
$0.80-20.00%
$0.20 (-20.00%) • Dec 5
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.9
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.94
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.88
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for WWHC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.79 – $0.81
TARGET (TP)$0.92
STOP LOSS$0.74
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.64
52W High$2.00
52W Low$0.50
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2021 | FY2020 | FY2019 |
|---|---|---|---|
| Revenue | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A |
| Operating Income | $-9,240 | $4 | $-2,100 |
| Net Income | $-9,240 | $-2,550,366 | $-2,099 |
| Net Margin | N/A | N/A | N/A |
| EPS | $-0.00 | $-8.65 | $-1.42 |
Company Overview
W World Corp., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent, which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome. The company was founded in 1990 and is headquartered in North Las Vegas, Nevada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
WWHCBeat Rate
47%
Last 15 quarters
Avg Surprise
-42.6%
EPS vs Estimate
Beats / Misses
7/6
2 met exactly
Latest EPS
$-200.00
Q1 2007
EPS Surprise History
Q4 04
-200.0%
$-70.00vs$-23.33
Q2 05
+40.0%
$70.00vs$50.00
Q3 05
+21.7%
$-36.00vs$-46.00
Q4 05
+19.0%
$-34.00vs$-42.00
Q2 06
+23.8%
$-32.00vs$-42.00
Q3 06
-16.7%
$-42.00vs$-36.00
Q4 06
0.0%
$-44.00vs$-44.00
Q1 07
-525.0%
$-200.00vs$-32.00
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2012 | Jul 30, 2012 | — | — | — | — |
Q2 2012 | Apr 16, 2012 | — | — | — | — |
Q4 2011 | Oct 31, 2011 | — | — | — | — |
Q3 2011 | Aug 8, 2011 | — | — | — | — |
Q2 2011 | Apr 28, 2011 | — | — | — | — |
Q1 2007 | Mar 15, 2007 | $-32.00 | $-200.00 | -525.0% | ✗ MISS |
Q4 2006 | Nov 6, 2006 | $-44.00 | $-44.00 | 0.0% | = MET |
Q3 2006 | Aug 10, 2006 | $-36.00 | $-42.00 | -16.7% | ✗ MISS |
Q2 2006 | May 9, 2006 | $-42.00 | $-32.00 | +23.8% | ✓ BEAT |
Q4 2005 | Nov 3, 2005 | $-42.00 | $-34.00 | +19.0% | ✓ BEAT |
Q3 2005 | Jul 28, 2005 | $-46.00 | $-36.00 | +21.7% | ✓ BEAT |
Q2 2005 | Apr 28, 2005 | $50.00 | $70.00 | +40.0% | ✓ BEAT |
Q4 2004 | Oct 28, 2004 | $-23.33 | $-70.00 | -200.0% | ✗ MISS |
Q3 2004 | Jul 28, 2004 | $-60.00 | $-60.00 | 0.0% | = MET |
Q1 2004 | Mar 3, 2004 | $-60.00 | $-70.00 | -16.7% | ✗ MISS |
Q4 2003 | Nov 5, 2003 | $-70.00 | $-60.00 | +14.3% | ✓ BEAT |
Q4 2002 | Nov 6, 2002 | $-80.00 | $-100.00 | -25.0% | ✗ MISS |
Q3 2002 | Aug 5, 2002 | $-90.00 | $-60.00 | +33.3% | ✓ BEAT |
Q2 2002 | May 2, 2002 | $-70.00 | $-90.00 | -28.6% | ✗ MISS |
Q4 2001 | Nov 6, 2001 | $-50.00 | $-40.00 | +20.0% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about WWHC
What is WWHC's current stock price?
W World Corp. (WWHC) is currently trading at $0.80 per share. The stock has moved -20.00% today.
What is the analyst price target for WWHC?
No analyst price targets are currently available for this stock.
What sector is W World Corp. in?
W World Corp. operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the OTC exchange.
What is WWHC's market cap?
W World Corp. has a market capitalization of $0.08 billion, making it a small-cap company.
Does WWHC pay dividends?
No, W World Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorATAQF
Altimar Acquisition Corp. III
$0.00
Mkt Cap: $0.1B
BUUZ
CalEthos, Inc.
$3.50
Mkt Cap: $0.1B
CHAA
Catcha Investment Corp
$8.90
Mkt Cap: $0.1B
CREEF
Crescera Capital Acquisition Corp.
$10.94
Mkt Cap: $0.1B
NMTT
Nimtech Corp.
$1.00
Mkt Cap: $0.1B
OCAX
OCA Acquisition Corp.
$11.60
Mkt Cap: $0.1B
PORT
Southport Acquisition Corporation
$11.99
Mkt Cap: $0.1B
RMGCF
RMG Acquisition Corp. III
$7.06
Mkt Cap: $0.1B
TRFE
Trustfeed Corp.
$0.37
Mkt Cap: $0.1B
Explore stocks similar to WWHC for comparison